Actinium to Present at BIO International Convention to Provide Updates on Actimab-A and Iomab-B Programs
NEW YORK, NY--(Marketwired - June 08, 2016) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or the "Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of …